Heart Valves Market Share

Heart Valves Market Share Analysis

A rising incidence of cardiovascular diseases has become a prominent concern due to the escalating number of fatalities attributed to these conditions. Numerous companies are fervently striving to introduce improved devices and accessories aimed at treating cardiovascular diseases, anticipating that the surge in disease prevalence will bolster market growth.

Among the various valve diseases, Aortic Valve Stenosis (AS) stands out as a commonly occurring condition, necessitating surgical or transcatheter valve replacement, especially prevalent in North America and Europe. Notably, a study published by John Muir Health in 2017 indicated that nearly five million Americans are diagnosed with heart valve disease annually, with an estimated 1.5 million individuals in the U.S. suffering from aortic stenosis. Alarmingly, an average of 80,000 to 85,000 Americans undergo Aortic Valve Replacement (AVR) procedures each year.

The advent of the Transcatheter Aortic Valve Replacement (TAVR) procedure has revolutionized the treatment of aortic stenosis, offering a safer, reproducible, and widely applicable alternative for patients. The burgeoning patient population requiring such interventions has substantially driven the demand for transcatheter devices. With their manifold advantages, the widespread adoption of these devices in most hospitals has considerably propelled market growth.

The burgeoning prevalence of cardiac diseases has resulted in a surge in surgical procedures, consequently escalating the demand for various medical devices. For example, according to the World Health Organization (WHO), cardiovascular diseases accounted for over 17.7 million deaths in 2015, constituting 31% of global fatalities. Procedures like bypass surgeries and managing high cholesterol levels have predominantly embraced transcatheter techniques due to their effectiveness and reduced discomfort, leading to increased adoption of these devices over recent years.

The prevalence of various cardiovascular diseases has been largely exacerbated by sedentary lifestyles, poor dietary habits, and lifestyle-related cardiovascular risk factors. WHO's 2014 findings indicated that approximately 422 million individuals were affected by diabetes, further highlighting the global burden of these diseases. Additionally, in 2016, a staggering 39% of adults aged 18 and above were overweight, with 13% classified as obese. These health trends have sparked greater demand for cardiovascular devices, anticipating an acceleration in market growth over the forthcoming decade.